Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Chlebowski

Showing results (111-120 of 379) with videos related to

Pageof 38
Sort By:
Climacteric : the Journal of the International Menopause Society|May 14, 2015
Reliable evidence from placebo-controlled, randomized, clinical trials for menopausal hormone therapy's influence on incidence and deaths from breast cancerR T Chlebowski, G L Anderson, R L Prentice, et al.
British Journal of Cancer|February 1, 1989
Combination versus sequential single agent chemotherapy in advanced breast cancer: associations with metastatic sites and long-term survival. The Western Cancer Study Group and The Southeastern Cancer Study GroupR T Chlebowski, R V Smalley, J M Weiner, et al.
The Oncologist|October 14, 2024
Opioid use and adverse health effects in breast cancer survivorsReina Haque, Lie Hong Chen, Jiaxiao Shi, et al.
Annals of Epidemiology|January 21, 2004
Differences between estimated caloric requirements and self-reported caloric intake in the women's health initiativeJames R Hebert, Ruth E Patterson, Malka Gorfine, et al.
The Breast Journal|October 1, 2020
Can Oncotype DX testing be omitted in invasive breast cancer patients with clinicopathologic factors predicting very high pretest probability of a concordant result?Sonam Kapadia, Sai Priyanka Gudiwada, Amy H Kaji, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 9, 2002
Survival impact of tamoxifen use for breast cancer risk reduction: projections from a patient-specific Markov modelNananda F Col, Robert J Goldberg, Richard K Orr, et al.
Archives of Dermatological Research|November 24, 2021
Association between baseline insulin resistance and psoriasis incidence: the Women's Health InitiativeAlfred A Chan, Houmin Li, Wendy Li, et al.
Cancer|September 1, 1981
Adriamycin and methyl-CCNU combination therapy in hepatocellular carcinoma: clinical and pharmacokinetic aspectsR T Chlebowski, K K Chan, M J Tong, et al.
Cancer Research|November 1, 1982
Clinical and pharmacokinetic effects of combined warfarin and 5-flourouracil in advanced colon cancerR T Chlebowski, C H Gota, K K Chan, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 21, 2011
Hormonal factors and risks of esophageal squamous cell carcinoma and adenocarcinoma in postmenopausal womenClara Bodelon, Garnet L Anderson, Mary Anne Rossing, et al.
Pageof 38

Showing results (111-120 of 379) with videos related to

Sort By:
Pageof 38
Climacteric : the Journal of the International Menopause Society|May 14, 2015
Reliable evidence from placebo-controlled, randomized, clinical trials for menopausal hormone therapy's influence on incidence and deaths from breast cancerR T Chlebowski, G L Anderson, R L Prentice, et al.
British Journal of Cancer|February 1, 1989
Combination versus sequential single agent chemotherapy in advanced breast cancer: associations with metastatic sites and long-term survival. The Western Cancer Study Group and The Southeastern Cancer Study GroupR T Chlebowski, R V Smalley, J M Weiner, et al.
The Oncologist|October 14, 2024
Opioid use and adverse health effects in breast cancer survivorsReina Haque, Lie Hong Chen, Jiaxiao Shi, et al.
Annals of Epidemiology|January 21, 2004
Differences between estimated caloric requirements and self-reported caloric intake in the women's health initiativeJames R Hebert, Ruth E Patterson, Malka Gorfine, et al.
The Breast Journal|October 1, 2020
Can Oncotype DX testing be omitted in invasive breast cancer patients with clinicopathologic factors predicting very high pretest probability of a concordant result?Sonam Kapadia, Sai Priyanka Gudiwada, Amy H Kaji, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 9, 2002
Survival impact of tamoxifen use for breast cancer risk reduction: projections from a patient-specific Markov modelNananda F Col, Robert J Goldberg, Richard K Orr, et al.
Archives of Dermatological Research|November 24, 2021
Association between baseline insulin resistance and psoriasis incidence: the Women's Health InitiativeAlfred A Chan, Houmin Li, Wendy Li, et al.
Cancer|September 1, 1981
Adriamycin and methyl-CCNU combination therapy in hepatocellular carcinoma: clinical and pharmacokinetic aspectsR T Chlebowski, K K Chan, M J Tong, et al.
Cancer Research|November 1, 1982
Clinical and pharmacokinetic effects of combined warfarin and 5-flourouracil in advanced colon cancerR T Chlebowski, C H Gota, K K Chan, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 21, 2011
Hormonal factors and risks of esophageal squamous cell carcinoma and adenocarcinoma in postmenopausal womenClara Bodelon, Garnet L Anderson, Mary Anne Rossing, et al.
Pageof 38